Answers are grounded in this paper and cite their sources.
When matched by stage, inv-IPMN has superior survival after resection compared with PDAC. This disparity is greatest in node-negative and least in node-positive disease. These findings suggest the behaviors of inv-IPMN and PDAC, although different, converge with advancing American Joint Committee on Cancer stage because of a greater proportion of tubular subtype.
No takes yet. Share an insight, caveat, or question.
Waters et al. (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: